Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-22-010392

Chief Scientific Officer bought 3,250 shares at $0.46 ($1,495)

From the SEC's structured data for this filing

Trades in this filing

Blouse Grant E. · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-09 Purchase : show line 1 in the form +3,250 $0.46 $1,495 6,167 D
Open-market purchases · 3,250 sh · avg $0.46 · $1,495
Loading xslF345X03/doc4.xml…